CORVIDIA
Corvidia Therapeutics is a clinical stage company focused on the research, development, and commercialization of transformative therapies for cardio-renal diseases. The Company is currently developing potential treatments for chronic kidney disease with atherosclerotic cardiovascular disease and inflammation, and high triglyceride-induced acute pancreatitis.
CORVIDIA
Social Links:
Industry:
Biotechnology Genetics Health Care Medical Therapeutics
Founded:
2014-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.corvidiatx.com
Total Employee:
11+
Status:
Active
Contact:
781-205-4755
Total Funding:
86.83 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail WordPress 5.8 Mimecast Dyn DNS SingleHop
Current Advisors List
Founder
Investors List
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Convertible Note - Corvidia
Sofinnova Partners
Sofinnova Partners investment in Series B - Corvidia
MedImmune
MedImmune investment in Series B - Corvidia
Andera Partners
Andera Partners investment in Series B - Corvidia
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Corvidia
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series B - Corvidia
Venrock
Venrock investment in Series B - Corvidia
Fresenius Medical Care
Fresenius Medical Care investment in Series B - Corvidia
Apple Tree Partners
Apple Tree Partners investment in Series B - Corvidia
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Series B - Corvidia
Official Site Inspections
http://www.corvidiatx.com
- Host name: 172.67.141.32
- IP address: 172.67.141.32
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Corvidia"
Corvidia - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 781-205-4755 Corvidia Therapeutics is a clinical stage company focused on the research, development, and commercialization of transformative therapies for cardio-renal diseases.See details»
Novo Nordisk acquires Corvidia - 2020-06-11 - Crunchbase
Jun 11, 2020 Acquiring Organization: Novo Nordisk Novo Nordisk is a healthcare company that produces and distributes insulin and other diabetes drugs to treat chronic diseases. ... Recent …See details»
Sofinnova Partners Announces Sale of Corvidia Therapeutics to …
Jun 11, 2020 Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings …See details»
Corvidia - Overview, News & Similar companies | ZoomInfo.com
Jun 12, 2020 Corvidia contact info: Phone number: (781) 205-4755 Website: www.corvidiatx.com What does Corvidia do? Corvidia Therapeutics is a clinical stage …See details»
Corvidia Therapeutics - PitchBook
Information on acquisition, funding, cap tables, investors, and executives for Corvidia Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Corvidia - VentureRadar
Website: http://corvidiatx.com. Corvidia Therapeutics is a clinical stage company focused on the research, development and commercialization of transformative ...See details»
Corvidia Therapeutics Company Overview, Contact Details
Mar 24, 2020 [email protected]: 5%. See more formats. Frequently Asked Questions Where is Corvidia Therapeutics 's headquarters located? Corvidia Therapeutics 's main headquarters …See details»
Corvidia Therapeutics - LinkedIn
At Corvidia Therapeutics, we are creating precision therapies by using the science of genomics in new ways. Through random genetic mutation, nature conducts experiments, subtly changing how key ...See details»
Sofinnova Partners Announces Sale of Corvidia …
Jun 11, 2020 For more information, please visit: www.corvidiatx.com Contacts Media Contacts: Bommy Lee Head of Communications, Sofinnova Partners [email protected] +33 (0) 6 47 71 38 11See details»
Novo Nordisk to acquire Corvidia Therapeutics for …
Jun 12, 2020 Novo Nordisk to acquire Corvidia Therapeutics for $725m. Danish healthcare company Novo Nordisk has signed a definitive agreement to acquire US-based Corvidia Therapeutics, which develops and commercialises …See details»
Novo Nordisk to acquire Corvidia Therapeutics and expand …
Jun 11, 2020 Learn more at: www.corvidiatx.com. About Novo Nordisk Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is …See details»
Novo Nordisk to Acquire Corvidia Therapeutics for $725M Cash
Jun 12, 2020 Novo Nordisk A/S NVO announced that it has agreed to buy AstraZeneca Plc’s AZN spin-off, Corvidia Therapeutics, for an upfront payment of $725 million in cash. With the …See details»
News Details - Novo Nordisk
Learn more at: www.corvidiatx.com. About Novo Nordisk Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive …See details»
Corvidia Therapeutics Raises $26M in a Series A Financing, Led by ...
Feb 18, 2016 For more information, please visit: www.corvidiatx.com. PRESS CONTACTS For Corvidia Therapeutics Media Contact: Paula Schwartz, [email protected], Tel: +1 917-322 …See details»
Corvidia Therapeutics Secures $60 Million in Series B Funding to ...
Apr 25, 2018 For more information, please visit www.corvidiatx.com. Contacts Press Inquiries: McDougall Communications on behalf of Corvidia Therapeutics Inc. Elizabeth Harness, +1 …See details»
Corvidia Therapeutics Appoints Marc de Garidel as Chief Executive ...
Mar 29, 2018 WALTHAM, Mass.--(BUSINESS WIRE)-- Corvidia Therapeutics Inc., a leading clinical stage biotechnology company, today announced the appointment of Marc de Garidel …See details»
Corvidia Therapeutics Announces Publication in Science …
WALTHAM, Mass, Jan. 29, 2020 /PRNewswire/ -- Corvidia Therapeutics, a clinical stage company focused on the research, development and commercialization of transformative …See details»
Corvidia Therapeutics Initiates Phase 2b Dose-Finding Study for ...
Jun 13, 2019 WALTHAM, Mass.--(BUSINESS WIRE)-- Corvidia Therapeutics Inc., a clinical stage biotechnology company, announced today the initiation of patient screening for a Phase …See details»
Corvidia Therapeutics to Present New Data at the American Heart ...
WALTHAM, Mass., Nov. 14, 2019 /PRNewswire/ -- Corvidia Therapeutics, a clinical stage company focused on the research, development and commercialization of transformative …See details»
Corvidia Therapeutics to Present New Data at ASN Kidney Week …
WALTHAM, Mass., Nov. 6, 2019 /PRNewswire/ -- Corvidia Therapeutics, a clinical stage company focused on the research, development and commercialization of transformative therapies in …See details»